You searched for "ototoxicity"

113 results found

Are we now safe at work?

Fifty years is a long time, yet the years pass in a blink of an eye. Where are we in comparison to where we were then, in terms of the occupational protection from noise exposure and ototoxicity, other than being...

Precision and personalised genomic and epigenomic medicine in audiology/hearing loss

A detailed look at the pathogenesis of acquired hearing loss due to exposure to ototoxicity during pregnancy or shortly after birth. Insights from genomic medicine have shown that, along with environmental factors causing epigenetic alterations, hearing loss may be caused...

Assessing extended high-frequency hearing

The frequency range of human hearing spans 20 Hz to 20 kHz. In the UK, standard audiometry usually assesses 0.25–8 kHz; the extended high frequencies (EHFs) are those above 8 kHz. The importance of assessing EHF hearing has been increasingly...

Human immunodeficiency virus and hearing impairment

With an estimated 36.7 million individuals living with HIV / AIDS and literature reporting that these conditions contribute to hearing loss, it is surprising that more focus and resources are not employed to tackle this major hearing health concern. Yolandé...

BAPA Annual Conference 2026

Sabarinath Vijayakumar, ST5 Audiovestibular Medicine, Royal Derby HospitalsThe BAPA Annual Conference 2026 was held virtually on 30 January 2026 and was attended by over 70 delegates from across the world. Participants mainly comprised consultant audiovestibular physicians, consultant paediatricians, paediatric audiologists...

36th World Congress of Audiology 2024

Ebru Zeren, Audiologist, Mid and South Essex University Hospitals GroupWhat a fast paced, thoroughly informative four days we had in Paris! This amazing event gathered professionals from across the globe, from Australia to Africa and from America to Europe, to...

Current applications and advancements in clinical OAEs

During the past 80 years, British hearing scientists and audiologists have made important contributions to the scientific investigation and clinical application of otoacoustic emissions (OAEs). As early as 1946, Thomas Gold conducted pioneering research in the Cavendish Laboratory at Cambridge...

COOL therapy for cisplatin-induced hearing loss

Cisplatin is a commonly used cancer therapy, with nearly 50% of patients undergoing chemotherapy receiving cisplatin as part of their regimen [1]. Depending on the dose, incidence of hearing loss has been reported as 12-100% in adults, and 37-94% in...

Peter McKelvie 1932 – 2026

Peter McKelvie, an outstanding head & neck surgeon and oncologist, died on 6 February aged 93. He suffered a spontaneous subdural haemorrhage. British otolaryngology has lost the most remarkable talent of his generation. He combined a prodigious intellect with effortless...

BAAP National Audit Meeting

Sabarinath Vijayakumar, ST5 Registrar in Audiovestibular medicine, Royal Derby Hospital. The British Association of Audiovestibular Physicians (BAAP) hosted its 2025 National Audit Meeting online in June. This meeting brought together members, consultants and trainees in audiovestibular medicine from across the...

The Academy Research Conference (ARC) 2025

Student Academy of Audiology

Drug side-effects on audiological and vestibular testing

Are they a malingerer? Or perhaps they are inattentive? It may be their drugs! Robert DiSogra considers the side-effects of medication on the test subject. The audiogram serves many purposes in clinical practice. For the audiologist, it helps to differentiate...